当前位置:首页 - 行情中心 - 百洋医药(301015) - 财务分析 - 现金流量表

百洋医药

(301015)

  

流通市值:120.04亿  总市值:120.05亿
流通股本:5.26亿   总股本:5.26亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,244,391,700.748,301,581,715.216,304,553,603.474,328,271,152.39
  收到其他与经营活动有关的现金9,569,817.25138,096,365.7116,424,960.392,090,949.82
  经营活动现金流入小计2,253,961,517.998,439,678,080.916,420,978,563.774,420,362,102.21
  购买商品、接受劳务支付的现金1,597,214,977.614,745,735,338.443,771,991,577.062,692,725,011.33
  支付给职工以及为职工支付的现金213,966,925.35707,241,369.1551,404,350.07366,869,782.7
  支付的各项税费116,082,734.08641,347,842.61451,986,423.21323,491,104.13
  支付其他与经营活动有关的现金303,780,054.341,410,899,925.91,024,178,648.22645,511,546.65
  经营活动现金流出小计2,231,044,691.387,505,224,476.055,799,560,998.564,028,597,444.81
  经营活动产生的现金流量净额22,916,826.61934,453,604.86621,417,565.21391,764,657.4
二、投资活动产生的现金流量:
  收回投资收到的现金87,461,562.8340,000,000230,000,000130,000,000
  取得投资收益收到的现金602,436.727,701,860.36,771,532.946,040,308.44
  处置固定资产、无形资产和其他长期资产收回的现金净额2,500402,699.429,134.429,134.4
  投资活动现金流入小计88,066,499.52348,104,559.7236,800,667.34136,069,442.84
  购建固定资产、无形资产和其他长期资产支付的现金46,316,225.16288,930,824.87198,271,915.1290,772,573.22
  投资支付的现金229,686,883.89647,979,490.24568,098,746.96326,000,000
  投资活动现金流出小计276,003,109.05936,910,315.11766,370,662.08416,772,573.22
  投资活动产生的现金流量净额-187,936,609.53-588,805,755.41-529,569,994.74-280,703,130.38
三、筹资活动产生的现金流量:
  吸收投资收到的现金-980,000980,000980,000
  其中:子公司吸收少数股东投资收到的现金-980,000980,000980,000
  取得借款收到的现金1,010,989,043.512,287,551,589.532,002,726,449.91,838,701,348.45
  收到其他与筹资活动有关的现金101,026,990.31199,285,074.98231,979,024.82307,000,919.47
  筹资活动现金流入小计1,112,016,033.822,487,816,664.512,235,685,474.722,146,682,267.92
  偿还债务支付的现金574,376,957.581,260,341,663.761,136,468,352.05954,064,439.1
  分配股利、利润或偿付利息支付的现金18,497,855.82502,768,596.16469,123,784.76439,251,640.77
  其中:子公司支付给少数股东的股利、利润315,00035,197,963.6518,539,459.656,400,000
  支付其他与筹资活动有关的现金13,638,530.75359,227,598.78287,221,716.98276,041,706.77
  筹资活动现金流出小计606,513,344.152,122,337,858.71,892,813,853.791,669,357,786.64
  筹资活动产生的现金流量净额505,502,689.67365,478,805.81342,871,620.93477,324,481.28
四、汇率变动对现金及现金等价物的影响-4,424,046.32-9,730,307.46-6,340,154.17-3,208,683.17
五、现金及现金等价物净增加额336,058,860.43701,396,347.8428,379,037.23585,177,325.13
  加:期初现金及现金等价物余额1,923,942,541.851,222,546,194.051,222,546,194.051,222,546,194.05
  期末现金及现金等价物余额2,260,001,402.281,923,942,541.851,650,925,231.281,807,723,519.18
补充资料:
  净利润-571,929,272.87-211,406,109.96
  资产减值准备-54,727,812.82-38,005,850.23
  固定资产和投资性房地产折旧-62,929,049.04-30,266,722.72
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-62,929,049.04-30,266,722.72
  无形资产摊销-23,126,318.47-11,268,396.99
  长期待摊费用摊销-10,922,515.7-2,793,638.25
  处置固定资产、无形资产和其他长期资产的损失--520,328.84--1,800
  固定资产报废损失-601,655.43-166,348.3
  公允价值变动损失--73,356,424.42-25,747,207.09
  财务费用-103,652,681.68-51,450,082.98
  投资损失--23,153,668.53-15,444,667.73
  递延所得税--29,725,684.97--37,798,741.72
  其中:递延所得税资产减少--28,683,000.91--26,040,584.05
    递延所得税负债增加--1,042,684.06--11,758,157.67
  存货的减少--11,685,641.22-123,054,118.11
  经营性应收项目的减少-150,190,559.2-198,390,721.59
  经营性应付项目的增加-61,810,383.76--292,953,899.67
  现金的期末余额-1,912,084,455.36-1,798,099,280.48
  减:现金的期初余额-1,212,445,674.09-1,212,445,674.09
  加:现金等价物的期末余额-11,858,086.49-9,624,238.7
  减:现金等价物的期初余额-10,100,519.96-10,100,519.96
  现金及现金等价物的净增加额-701,396,347.8-585,177,325.13
公告日期2026-04-292026-04-292025-10-302025-08-29
审计意见(境内)标准无保留意见
TOP↑